Disease | breast cancer |
Symptom | C2711227|hepatic steatosis |
Sentences | 2 |
PubMedID- 20658461 | Approximately 43% of breast cancer patients treated with tamoxifen develop hepatic steatosis. |
PubMedID- 26273591 | In another study of 105 breast cancer patients treated with tamoxifen, hepatic steatosis was recognized in the majority of patients within the first 2 years of receiving adjuvant tamoxifen, with only half of the patients having increased transaminase levels . |
Page: 1